Abstract 581: Hyperglycemia Acutely Increases Cytosolic Reactive Oxygen Species (ROS) via O-linked GlcNAcylation Activation of CaMKII in Mouse Ventricular Myocytes

Shan Lu,Zhandi Liao,Julie Bossuyt,Donald Bers
DOI: https://doi.org/10.1161/res.125.suppl_1.581
IF: 23.213
2019-08-02
Circulation Research
Abstract:Diabetes mellitus (DM) is a complex, multisystem disease, affecting large populations worldwide. Chronic CaMKII activation in autonomous states can occur in DM and contribute to arrhythmogenesis. Diabetic hyperglycemia has been shown to activate CaMKII by (1) O-linked attachment of N-acetylglucosamine (O-GlcNAc) at S280 leading to arrhythmia and (2) a ROS-CaMKII pathway, and these can increase post-infarction mortality. However, the mechanism by which high extracellular [glucose] (Hi-Glu) promotes ROS generation that may synergize with CaMKII activation remains unknown. Here we tested the mechanism by which extracellular Hi-Glu influences ROS production in adult ventricular myocytes, using H 2 DCFDA to measure ROS. Hi-Glu (30 mM) significantly increased the rate of ROS generation, which was prevented in myocytes pretreated with CaMKII inhibitor KN-93 or from both global CaMKIIδ-KO and cardiac specific CaMKIIδ-KO. CaMKII-KO or inhibition prevented Hi-Glu induced sarcoplasmic reticulum (SR) Ca 2+ release events (Ca 2+ sparks and waves). Thus, CaMKII activation is required for Hi-Glu induced ROS generation in cardiomyocytes. Next, we tested the involvement of O-GlcNAc-CaMKII pathway. Inhibition of de- GlcNAcylation by 100nM Thiamet G (Thm-G) mimicked the effect of Hi-Glu, enhancing the rate of ROS. Also, inhibition of GlcNAcylation (OSMI-1) blocked the ROS induction triggered by either Hi-Glu or Thm-G. Moreover, in new CRSPR-based knock-in mouse in which the functional GlcNAc site on CaMKIIδ was ablated (S280A) neither Hi-Glu nor Thm-G induced myocyte ROS generation. So CaMKIIδ-S280 is required for the Hi-Glu-induced (and GlcNAc-dependent) ROS production. To identify the ROS source(s), we used different inhibitors: NOX2 inhibitor (Gp91-ds-tat peptide), NOX4 inhibitors (GKT137831), Mito Tempo and NOS pathway inhibitors (L-NAME, L-NIO and L-NPA). Only NOX2 inhibition prevented Hi-Glu/Thm-G induced ROS generation. In summary, our data suggests that diabetic hyperglycemia acutely induces ROS production via an O-GlcNAc-CaMKII dependent pathway and the ROS induced by hyperglycemia is mainly from cytosolic NOX2 complex.
cardiac & cardiovascular systems,peripheral vascular disease,hematology
What problem does this paper attempt to address?